BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 36930371)

  • 1. Organ Infiltration and Patient Risk After Multivisceral Surgery for Primary Retroperitoneal Liposarcomas.
    Improta L; Pasquali S; Iadecola S; Barisella M; Fiore M; Radaelli S; Colombo C; Alloni R; Callegaro D; Valeri S; Miceli R; Gronchi A
    Ann Surg Oncol; 2023 Jul; 30(7):4500-4510. PubMed ID: 36930371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and Adverse Prognostic Implications of Histopathologic Organ Invasion in Primary Retroperitoneal Sarcoma.
    Fairweather M; Wang J; Jo VY; Baldini EH; Bertagnolli MM; Raut CP
    J Am Coll Surg; 2017 May; 224(5):876-883. PubMed ID: 28147251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multi-institutional validation study of prognostic nomograms for retroperitoneal sarcoma.
    Squires MH; Ethun CG; Donahue EE; Benbow JH; Anderson CJ; Jagosky MH; Salo JC; Hill JS; Ahrens W; Prabhu RS; Livingston MB; Gower NL; Needham M; Trufan SJ; Fields RC; Krasnick BA; Bedi M; Abbott DE; Schwartz P; Votanopoulos K; Chouliaras K; Grignol V; Roggin KK; Tseng J; Poultsides G; Tran TB; Cardona K; Howard JH
    J Surg Oncol; 2021 Oct; 124(5):829-837. PubMed ID: 34254691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncological outcomes after major vascular resections for primary retroperitoneal liposarcoma.
    Spolverato G; Chiminazzo V; Lorenzoni G; Fiore M; Radaelli S; Sanfilippo R; Sangalli C; Barisella M; Callegaro D; Gronchi A
    Eur J Surg Oncol; 2021 Dec; 47(12):3004-3010. PubMed ID: 34364722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics and Outcomes of Locally Recurrent Retroperitoneal Sarcoma After First Relapse in a Single Tertiary Asian Centre and Applicability of the
    Lim HJ; Wong R; Koh YS; Ho ZS; Ong CJ; Farid M; Teo CCM
    Front Oncol; 2021; 11():730292. PubMed ID: 34900680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical Management of Primary Retroperitoneal Sarcomas: Rationale for Selective Organ Resection.
    Fairweather M; Wang J; Jo VY; Baldini EH; Bertagnolli MM; Raut CP
    Ann Surg Oncol; 2018 Jan; 25(1):98-106. PubMed ID: 29067605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retroperitoneal liposarcomas: follow-up analysis of dedifferentiation after clinicopathologic reexamination of 86 liposarcomas and malignant fibrous histiocytomas.
    Fabre-Guillevin E; Coindre JM; Somerhausen Nde S; Bonichon F; Stoeckle E; Bui NB
    Cancer; 2006 Jun; 106(12):2725-33. PubMed ID: 16688768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concomitant organ resection does not improve outcomes in primary retroperitoneal well-differentiated liposarcoma: A retrospective cohort study at a major sarcoma center.
    Ikoma N; Roland CL; Torres KE; Chiang YJ; Wang WL; Somaiah N; Mann GN; Hunt KK; Cormier JN; Feig BW
    J Surg Oncol; 2018 May; 117(6):1188-1194. PubMed ID: 29228466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting Survival in Patients Undergoing Resection for Locally Recurrent Retroperitoneal Sarcoma: A Study and Novel Nomogram from TARPSWG.
    Raut CP; Callegaro D; Miceli R; Barretta F; Rutkowski P; Blay JY; Lahat G; Strauss DC; Gonzalez R; Ahuja N; Grignani G; Quagliuolo V; Stoeckle E; De Paoli A; Pillarisetty VG; Nessim C; Swallow CJ; Bagaria S; Canter R; Mullen J; Gelderblom HJ; Pennacchioli E; van Coevorden F; Cardona K; Fiore M; Fairweather M; Gronchi A
    Clin Cancer Res; 2019 Apr; 25(8):2664-2671. PubMed ID: 30723141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radical Nephrectomy for Primary Retroperitoneal Liposarcoma Near the Kidney has a Beneficial Effect on Disease-Free Survival.
    Rhu J; Cho CW; Lee KW; Park H; Park JB; Choi YL; Kim SJ
    World J Surg; 2018 Jan; 42(1):254-262. PubMed ID: 28808758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiotherapy for retroperitoneal liposarcoma: A report from the Transatlantic Retroperitoneal Sarcoma Working Group.
    Haas RLM; Bonvalot S; Miceli R; Strauss DC; Swallow CJ; Hohenberger P; van Coevorden F; Rutkowski P; Callegaro D; Hayes AJ; Honoré C; Fairweather M; Gladdy R; Jakob J; Szacht M; Fiore M; Chung PW; van Houdt WJ; Raut CP; Gronchi A
    Cancer; 2019 Apr; 125(8):1290-1300. PubMed ID: 30602058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histologic subtype and margin of resection predict pattern of recurrence and survival for retroperitoneal liposarcoma.
    Singer S; Antonescu CR; Riedel E; Brennan MF
    Ann Surg; 2003 Sep; 238(3):358-70; discussion 370-1. PubMed ID: 14501502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retroperitoneal and Mesenteric Liposarcomas.
    Siew CCH; Apte SS; Baia M; Gyorki DE; Ford S; van Houdt WJ
    Surg Oncol Clin N Am; 2022 Jul; 31(3):399-417. PubMed ID: 35715141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multivisceral resection for retroperitoneal liposarcoma-is it worth it? A 20-year single-center experience.
    Teixeira FR; Arakaki MS; Lima HVG; Ferreira FO; Menegozzo CAM; Silva ER; Montero EFS; Oya T; Lima LC; Akaishi EH; Utiyama EM
    Surg Today; 2023 Oct; 53(10):1181-1187. PubMed ID: 37606758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [An exceptional association between retroperitoneal dedifferentiated liposarcoma and well differentiated pericolonic liposarcoma: about a case].
    Sinaa M
    Pan Afr Med J; 2016; 25():254. PubMed ID: 28293370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing Multivisceral Resection with Tumor-only Resection of Liposarcoma Using the Win Ratio.
    Gorji L; Nikahd M; Onuma A; Tsilimigras D; Madison Hyer J; Ruff S; Ilyas FZ; Contreras C; Grignol VP; Kim A; Pollock R; Pawlik TM; Beane JD
    Ann Surg Oncol; 2024 May; 31(5):3389-3396. PubMed ID: 38347333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent retroperitoneal sarcomas: Clinical outcomes of surgical treatment and prognostic factors.
    Tropea S; Mocellin S; Damiani GB; Stramare R; Aliberti C; Del Fiore P; Rossi CR; Rastrelli M
    Eur J Surg Oncol; 2021 May; 47(5):1201-1206. PubMed ID: 32950313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retroperitoneal sarcomas: patterns of care at diagnosis, prognostic factors and focus on main histological subtypes: a multicenter analysis of the French Sarcoma Group.
    Toulmonde M; Bonvalot S; Méeus P; Stoeckle E; Riou O; Isambert N; Bompas E; Jafari M; Delcambre-Lair C; Saada E; Le Cesne A; Le Péchoux C; Blay JY; Piperno-Neumann S; Chevreau C; Bay JO; Brouste V; Terrier P; Ranchère-Vince D; Neuville A; Italiano A;
    Ann Oncol; 2014 Mar; 25(3):735-742. PubMed ID: 24567518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single centre 30-year experience in treating retroperitoneal liposarcomas.
    Homsy P; Heiskanen I; Sampo M; Rönty M; Tukiainen E; Blomqvist C
    J Surg Oncol; 2020 Nov; 122(6):1163-1172. PubMed ID: 32668067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognosis and survival of patients diagnosed with well-differentiated and dedifferentiated retroperitoneal liposarcoma.
    Osuna-Soto J; Caro Cuenca T; Sanz-Zorrilla A; Torrecilla-Martínez A; Ortega Salas R; Leiva-Cepas F
    Cir Esp (Engl Ed); 2022 Oct; 100(10):622-628. PubMed ID: 35753575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.